儿童扁桃体腺样体低温等离子射频消融术规范化治疗临床实践指南

2021-02-07 临床耳鼻咽喉头颈外科杂志.2021.35(3):193-199.

应用低温等离子消融技术进行扁桃体腺样体切除在我国已经10余年,然而,仍缺乏系统性的使用规范,制约了该技术在儿童扁桃体腺样体手术中的应用推广。因此,亟需制订儿童扁桃体腺样体低温等离子射频消融术规范化治疗

中文标题:

儿童扁桃体腺样体低温等离子射频消融术规范化治疗临床实践指南

发布机构:

发布日期:

2021-02-07

简要介绍:

应用低温等离子消融技术进行扁桃体腺样体切除在我国已经10余年,然而,仍缺乏系统性的使用规范,制约了该技术在儿童扁桃体腺样体手术中的应用推广。因此,亟需制订儿童扁桃体腺样体低温等离子射频消融术规范化治疗临床实践指南,目的是规范等离子射频消融技术在我国儿童扁桃体腺样体手术中的应用,以指导广大相关医务工作者的临床实践。

相关资料下载:
[AttachmentFileName(sort=1, fileName=儿童扁桃体腺样体低温等离子射频消融术规范化治疗临床实践指南_.pdf)] GetToolGuiderByIdResponse(projectId=1, id=d6fde1c002063e8e, title=儿童扁桃体腺样体低温等离子射频消融术规范化治疗临床实践指南, enTitle=, guiderFrom=临床耳鼻咽喉头颈外科杂志.2021.35(3):193-199., authorId=0, author=, summary=应用低温等离子消融技术进行扁桃体腺样体切除在我国已经10余年,然而,仍缺乏系统性的使用规范,制约了该技术在儿童扁桃体腺样体手术中的应用推广。因此,亟需制订儿童扁桃体腺样体低温等离子射频消融术规范化治疗, cover=https://img.medsci.cn/2021223/1614011177389_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sun Feb 07 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>应用低温等离子消融技术进行扁桃体腺样体切除在我国已经10余年,然而,仍缺乏系统性的使用规范,制约了该技术在儿童扁桃体腺样体手术中的应用推广。因此,亟需制订儿童扁桃体腺样体低温等离子射频消融术规范化治疗临床实践指南,目的是规范等离子射频消融技术在我国儿童扁桃体腺样体手术中的应用,以指导广大相关医务工作者的临床实践。</p> </div> </div> </div>, tagList=[TagDto(tagId=2226, tagName=扁桃体)], categoryList=[CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=30, categoryName=耳鼻咽喉科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2226, guiderKeyword=扁桃体, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=15438, appHits=330, showAppHits=0, pcHits=895, showPcHits=15101, likes=1, shares=26, comments=14, approvalStatus=1, publishedTime=Tue Feb 23 00:55:10 CST 2021, publishedTimeString=2021-02-07, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Feb 23 00:26:26 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 13:25:07 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=儿童扁桃体腺样体低温等离子射频消融术规范化治疗临床实践指南_.pdf)])
儿童扁桃体腺样体低温等离子射频消融术规范化治疗临床实践指南_.pdf
下载请点击:
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1207736, encodeId=33ec120e73691, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c5c2439965, createdName=123d2042m88暂无昵称, createdTime=Fri Apr 01 06:54:29 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195236, encodeId=832b119523691, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200620/aa639dfc8a1a4edf8fd1a054e00988dd/d30946ee96694a4f8aa034f2e536c052.jpg, createdBy=23f62697515, createdName=ms5000001417824766, createdTime=Sat Feb 19 23:26:01 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187661, encodeId=6ee5118e66157, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55b71373526, createdName=anny_yhz, createdTime=Mon Jan 24 12:10:18 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180817, encodeId=531d118081ee4, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210310/ca98b04c89bd4bebb96afdd82fdfbf2b/814250fae95e4386a9de15f63120f0ab.jpg, createdBy=75422345559, createdName=宙斯, createdTime=Wed Jan 05 10:59:07 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068176, encodeId=896410681e66a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57e51563612, createdName=xiefuquan2005, createdTime=Mon Nov 08 17:38:18 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2022-04-01 123d2042m88暂无昵称

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1207736, encodeId=33ec120e73691, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c5c2439965, createdName=123d2042m88暂无昵称, createdTime=Fri Apr 01 06:54:29 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195236, encodeId=832b119523691, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200620/aa639dfc8a1a4edf8fd1a054e00988dd/d30946ee96694a4f8aa034f2e536c052.jpg, createdBy=23f62697515, createdName=ms5000001417824766, createdTime=Sat Feb 19 23:26:01 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187661, encodeId=6ee5118e66157, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55b71373526, createdName=anny_yhz, createdTime=Mon Jan 24 12:10:18 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180817, encodeId=531d118081ee4, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210310/ca98b04c89bd4bebb96afdd82fdfbf2b/814250fae95e4386a9de15f63120f0ab.jpg, createdBy=75422345559, createdName=宙斯, createdTime=Wed Jan 05 10:59:07 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068176, encodeId=896410681e66a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57e51563612, createdName=xiefuquan2005, createdTime=Mon Nov 08 17:38:18 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2022-02-19 ms5000001417824766

    666

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1207736, encodeId=33ec120e73691, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c5c2439965, createdName=123d2042m88暂无昵称, createdTime=Fri Apr 01 06:54:29 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195236, encodeId=832b119523691, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200620/aa639dfc8a1a4edf8fd1a054e00988dd/d30946ee96694a4f8aa034f2e536c052.jpg, createdBy=23f62697515, createdName=ms5000001417824766, createdTime=Sat Feb 19 23:26:01 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187661, encodeId=6ee5118e66157, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55b71373526, createdName=anny_yhz, createdTime=Mon Jan 24 12:10:18 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180817, encodeId=531d118081ee4, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210310/ca98b04c89bd4bebb96afdd82fdfbf2b/814250fae95e4386a9de15f63120f0ab.jpg, createdBy=75422345559, createdName=宙斯, createdTime=Wed Jan 05 10:59:07 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068176, encodeId=896410681e66a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57e51563612, createdName=xiefuquan2005, createdTime=Mon Nov 08 17:38:18 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2022-01-24 anny_yhz

    谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1207736, encodeId=33ec120e73691, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c5c2439965, createdName=123d2042m88暂无昵称, createdTime=Fri Apr 01 06:54:29 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195236, encodeId=832b119523691, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200620/aa639dfc8a1a4edf8fd1a054e00988dd/d30946ee96694a4f8aa034f2e536c052.jpg, createdBy=23f62697515, createdName=ms5000001417824766, createdTime=Sat Feb 19 23:26:01 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187661, encodeId=6ee5118e66157, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55b71373526, createdName=anny_yhz, createdTime=Mon Jan 24 12:10:18 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180817, encodeId=531d118081ee4, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210310/ca98b04c89bd4bebb96afdd82fdfbf2b/814250fae95e4386a9de15f63120f0ab.jpg, createdBy=75422345559, createdName=宙斯, createdTime=Wed Jan 05 10:59:07 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068176, encodeId=896410681e66a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57e51563612, createdName=xiefuquan2005, createdTime=Mon Nov 08 17:38:18 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2022-01-05 宙斯

    666

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1207736, encodeId=33ec120e73691, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c5c2439965, createdName=123d2042m88暂无昵称, createdTime=Fri Apr 01 06:54:29 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195236, encodeId=832b119523691, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200620/aa639dfc8a1a4edf8fd1a054e00988dd/d30946ee96694a4f8aa034f2e536c052.jpg, createdBy=23f62697515, createdName=ms5000001417824766, createdTime=Sat Feb 19 23:26:01 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187661, encodeId=6ee5118e66157, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55b71373526, createdName=anny_yhz, createdTime=Mon Jan 24 12:10:18 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180817, encodeId=531d118081ee4, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210310/ca98b04c89bd4bebb96afdd82fdfbf2b/814250fae95e4386a9de15f63120f0ab.jpg, createdBy=75422345559, createdName=宙斯, createdTime=Wed Jan 05 10:59:07 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068176, encodeId=896410681e66a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57e51563612, createdName=xiefuquan2005, createdTime=Mon Nov 08 17:38:18 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2021-11-08 xiefuquan2005

    0